All News Top News Nov 8, 2019 Teva Announces $1.5 Billion Debt Tender Offers Learn More Share Top News Nov 8, 2019 Teva Announces Launch of $1,500,000,000 Offering of Senior Notes Learn More Share Top News Nov 7, 2019 Teva and Celltrion Announce the Availability of TRUXIMA® (rituximab-abbs) Injection, the First Biosimilar to Rituxan® (rituximab) in the United States Learn More Share Top News Nov 7, 2019 Teva Announces Appointment of New Chief Financial Officer Learn More Share Top News Nov 7, 2019 Teva Reports Third Quarter 2019 Financial Results Learn More Share
Top News Nov 7, 2019 Teva and Celltrion Announce the Availability of TRUXIMA® (rituximab-abbs) Injection, the First Biosimilar to Rituxan® (rituximab) in the United States Learn More